Endocrine Therapy Limitations | Evolving Cancer Approaches
SponsoredA Key Goal In First-Line HR+ mBC Is To Maximize Patients' Time On Endocrine Therapy. …Innovative Thinking · Targeted Approaches · Self-Activation · Progression-Free Survival
Types: Endocrine Therapy, Estrogen Therapy, HR+/HER2- mBC, ESR1 Mutation
